[Diversities in the treatment of patients with chronic obstructive lung disease].
Bronchial asthma and chronic obstructive lung disease are characterised by dyspnoea, cough and, during exacerbation, wheeze in some patients. The common pathophysiological element is obturation of the bronchial tree and chronic inflammation. These diseases differ, however, in location of the inflammatory process in the respiratory system, various degree of participation of inflammatory cells and inflammation mediators. These elements influence the effectiveness of treatment. In both diseases inhalant and systemic glucocorticosteroids, beta 2-mimetics, cholinolytics, theophylline. The reaction to these drugs is, however, different. In the paper, differences in treatment of these diseases are also discussed.
Kozielski
Jerzy
J
Klinika Ftizjopneumonologii Slaskiej Akademii Medycznej w Zabrzu.
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D006801:Humans; D010353:Patient Education as Topic; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents